Our collaboration with BioWorld Today

In line with our mission to bring only the most critical news and analysis to biotechnology readers like yourself, we've partnered with our friends at BioWorld Today on a special two-part editorial series. Part I runs today; John Carroll introduces it in the space above. Catch Part II in FierceBiotech on March 19, and a second-two part series follows in FiercePharma.

Drop me a line if you have ideas on how we can best continue satisfying your daily diet of biotech news on email, Twitter, or LinkedIn, and most of all--thanks for your readership. – Arsalan Arif, publisher

Suggested Articles

Moderna’s shares shrunk by nearly 5% before the long holiday weekend Thursday after a report out by Stat said the biotech was delaying its trial.

Keep your post-pandemic trials on track: learn how the right clinical supply chain partner can help sponsors avoid trial disruption. Read now>>

Helsinn Group and MEI Pharma penned a near $500 million biobucks pact for experimental blood cancer drug pracinostat back in 2016.